Login to Your Account

Pharma: Other News To Note

Friday, June 28, 2013
• Janssen Biotech Inc., of Spring House, Pa., part of Johnson & Johnson, of New Brunswick, N.J., and Johnson & Johnson Innovation established a research alliance with the Icahn School of Medicine at Mount Sinai to advance the scientific understanding of inflammatory bowel disease and the discovery of next-generation therapeutic solutions.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription